Coe Capital Management’s Amgen AMGN Stock Holding History

Coe Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,905	Closed	-$352K	–	80
2018 Q2	$352K	Hold	1,905	–	–	0.39%	67
2018 Q1	$325K	Sell	1,905 -190	-9%	-$34.9K	0.35%	72
2017 Q4	$364K	Hold	2,095	–	–	0.38%	69
2017 Q3	$391K	Buy	2,095 +50	+2%	+$8.86K	0.41%	70
2017 Q2	$352K	Buy	2,045 +140	+7%	+$22.8K	0.4%	69
2017 Q1	$313K	Hold	1,905	–	–	0.38%	73
2016 Q4	$279K	Hold	1,905	–	–	0.36%	74
2016 Q3	$318K	Hold	1,905	–	–	0.1%	188
2016 Q2	$290K	Hold	1,905	–	–	0.1%	196
2016 Q1	$286K	Hold	1,905	–	–	0.09%	197
2015 Q4	$309K	Hold	1,905	–	–	0.12%	170
2015 Q3	$263K	Hold	1,905	–	–	0.1%	179
2015 Q2	$292K	Buy	1,905 +200	+12%	+$32K	0.11%	200
2015 Q1	$273K	Sell	1,705 -200	-10%	-$31.5K	0.11%	180
2014 Q4	$303K	Buy	1,905 +200	+12%	+$31.2K	0.1%	203
2014 Q3	$239K	Hold	1,705	–	–	0.09%	185
2014 Q2	$202K	Hold	1,705	–	–	0.07%	194
2014 Q1	$210K	Buy	+1,705	New	+$207K	0.06%	224

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Coe Capital Management's AMGN Position: Q3 2018 in Review

Coe Capital Management sold out of Amgen (AMGN) in Q3 2018, closing a stake of 1,905 shares — an estimated $352K sold.

Coe Capital Management first reported a position in AMGN in Q1 2014 and held it in 18 quarters. The position peaked at $391K in Q3 2017. 1,796 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.

Coe Capital Management reported no remaining Amgen position as of Q3 2018 after selling out during the quarter.
Coe Capital Management sold 1,905 Amgen shares in Q3 2018, an estimated $352K.
Coe Capital Management first reported a position in Amgen in Q1 2014 and held it in 18 quarters.
Coe Capital Management's Amgen position peaked at $391K in Q3 2017.
1,796 funds tracked by Wall St. Rank held Amgen as of Q3 2018.

Based on Coe Capital Management's 13F filing for Q3 2018, filed 19 Nov 2018.